Schonfeld Strategic Advisors’s Rocket Pharmaceuticals RCKT Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $69.5K | Buy |
28,362
+16,930
| +148% | +$41.5K | ﹤0.01% | 1766 |
|
2025
Q1 | $76.3K | Buy |
+11,432
| New | +$76.3K | ﹤0.01% | 1914 |
|
2023
Q4 | – | Sell |
-10,400
| Closed | -$213K | – | 2009 |
|
2023
Q3 | $213K | Sell |
10,400
-19,724
| -65% | -$404K | ﹤0.01% | 1269 |
|
2023
Q2 | $599K | Buy |
+30,124
| New | +$599K | 0.01% | 1125 |
|
2023
Q1 | – | Sell |
-51,024
| Closed | -$999K | – | 2433 |
|
2022
Q4 | $999K | Sell |
51,024
-22,488
| -31% | -$440K | 0.01% | 1147 |
|
2022
Q3 | $1.17M | Buy |
+73,512
| New | +$1.17M | 0.01% | 1154 |
|
2022
Q1 | – | Sell |
-41,400
| Closed | -$903K | – | 2654 |
|
2021
Q4 | $903K | Sell |
41,400
-29,870
| -42% | -$652K | 0.01% | 924 |
|
2021
Q3 | $2.13M | Buy |
71,270
+35,067
| +97% | +$1.05M | 0.02% | 633 |
|
2021
Q2 | $1.6M | Sell |
36,203
-298
| -0.8% | -$13.2K | 0.02% | 752 |
|
2021
Q1 | $1.62M | Sell |
36,501
-3,111
| -8% | -$138K | 0.02% | 697 |
|
2020
Q4 | $2.17M | Buy |
39,612
+13,591
| +52% | +$746K | 0.03% | 551 |
|
2020
Q3 | $595K | Sell |
26,021
-24,934
| -49% | -$570K | 0.01% | 822 |
|
2020
Q2 | $1.07M | Buy |
+50,955
| New | +$1.07M | 0.03% | 550 |
|
2020
Q1 | – | Sell |
-36,435
| Closed | -$829K | – | 1442 |
|
2019
Q4 | $829K | Sell |
36,435
-39,165
| -52% | -$891K | 0.02% | 562 |
|
2019
Q3 | $881K | Sell |
75,600
-107,300
| -59% | -$1.25M | 0.03% | 503 |
|
2019
Q2 | $2.74M | Buy |
182,900
+158,300
| +643% | +$2.37M | 0.1% | 240 |
|
2019
Q1 | $432K | Sell |
24,600
-77,600
| -76% | -$1.36M | 0.02% | 734 |
|
2018
Q4 | $1.51M | Buy |
102,200
+77,200
| +309% | +$1.14M | 0.06% | 378 |
|
2018
Q3 | $616K | Buy |
+25,000
| New | +$616K | 0.03% | 535 |
|
2018
Q2 | – | Sell |
-24,460
| Closed | -$459K | – | 918 |
|
2018
Q1 | $459K | Buy |
+24,460
| New | +$459K | 0.03% | 494 |
|